An Overview of Chemoprevention: Current Status and Future Prospects
Open Access
- 1 November 1997
- journal article
- research article
- Published by Frontiers Media SA in Experimental Biology and Medicine
- Vol. 216 (2) , 133-141
- https://doi.org/10.3181/00379727-216-44163
Abstract
The optimal way of dealing with any disease is by prevention. This is particularly true of cancer, with all of its complexities. A major problem that exists for cancer prevention is that we do not know the cause of over 50% of cancers. Even when causes are known, serious difficulties often exist in removing them. To the extent that causality cannot be dealt with effectively, other strategies merit consideration. One is chemoprevention. A great strength of chemoprevention is that a large number of compounds can prevent the occurrence of cancer, and a variety of mechanisms exist for producing such protection. Much of this review deals with efficacy, toxicity, and mechanisms of action of chemopreventive agents. Gap areas in information are discussed, as well as opportunities for producing compounds with optimal attributes. Chemoprevention is not simple, and successes may not come quickly. However, for both the general population and, even more urgently, for individuals at high risk, chemoprevention has the potential of providing an important means for cancer prevention.This publication has 12 references indexed in Scilit:
- Prolactin effects on the dietary regulation of mouse mammary tumor virus proviral DNA expression.Proceedings of the National Academy of Sciences, 1990
- Colonic Hyperplasia and Hyperproliferation Induced by a Nutritional Stress Diet With Four Components of Western-Style DietJNCI Journal of the National Cancer Institute, 1990
- Aspirin use and chronic diseases: a cohort study of the elderly.BMJ, 1989
- Rapid single-dose model for lung tumor induction in A/J mice by 4-(methylnitrosainino)-1-(3-pyridyl)-1-butanone and the effect of dietCarcinogenesis: Integrative Cancer Research, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- INHIBITION OF BETA-PROPIOLACTONE-INDUCED NEOPLASIA OF THE FORESTOMACH AND LARGE BOWEL BY 4-MERCAPTOBENZENE SULFONATE IN MICE AND RATS1988
- SHORT-TERM HORMONE-TREATMENT AS A CHEMOPREVENTIVE METHOD AGAINST MAMMARY-CANCER INITIATION IN RATS1988
- DOSE-RELATED INHIBITION OF COLON CARCINOGENESIS BY DIETARY PIROXICAM, A NONSTEROIDAL ANTIINFLAMMATORY DRUG, DURING DIFFERENT STAGES OF RAT COLON-TUMOR DEVELOPMENT1987
- Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1,2-dithioI-3-thione (Oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustardCarcinogenesis: Integrative Cancer Research, 1986
- Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers.Journal of Epidemiology and Community Health, 1978